Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Pimagedine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pimagedine SCHEMBL28319709 | 0.97 | CYP1A2 (0.42) | — | |
| Pimagedine SCHEMBL27623862 | 0.97 | LMNA (0.47) | — | |
| Pimagedine SCHEMBL27784772 | 0.87 | TSHR (0.50) | — | |
| Pimagedine SCHEMBL6665719 | 0.87 | TSHR (0.50) | — | |
| Pimagedine SCHEMBL9952232 | 0.87 | TSHR (0.50) | — | |
| Pimagedine SCHEMBL40128 | 0.87 | — | — | |
| Oxalic Acid SCHEMBL507710 | 0.84 | TSHR (0.47) | — | |
| Pimagedine SCHEMBL3279095 | 0.84 | LMNA (0.53) | — | |
| Pimagedine SCHEMBL28272894 | 0.84 | TSHR (0.47) | — | |
| Oxalic Acid SCHEMBL507712 | 0.84 | TSHR (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118613260-A | Treatment of rheumatoid arthritis | 西奈克制药有限公司 | 2024-09-06 | — | — | CN | claimed |
| EP-4359383-A1 | SALTS OF PHENYL PYRROLE AMINOGUANIDINE AND POLYMORPHS OF PHENYL PYRROLE AMINOGUANIDINIUM SALTS | SynAct Pharma ApS (DK) | 2024-05-01 | — | — | EP | claimed |
| CN-117836271-A | Salts of phenylpyrrolaminoguanidine and polymorphs of phenylpyrrolaminoguanidine onium salts | 西奈克制药有限公司 | 2024-04-05 | — | — | CN | claimed |
| WO-2022268814-A1 | SALTS OF PHENYL PYRROLE AMINOGUANIDINE AND POLYMORPHS OF PHENYL PYRROLE AMINOGUANIDINIUM SALTS | SYNACT PHARMA APS (DK) | 2022-12-29 | — | — | WO | claimed |
| US-20150051328-A1 | ALKYL PHOSPHINATE POLYMER AND METHODS FOR PREPARING AND USING THE SAME | SHANGHAI HUIHAI CHEMICAL TECHNOLOGY CO., LTD. (CN) | 2015-02-19 | — | — | US | claimed |
| US-4149980-A | AMINOGUANIDINE SULFONATE OVERBASED COMPOUND | STANDARD OIL COMPANY (INDIANA) (US) | 1979-04-17 | — | — | US | claimed |
| US-20250032449-A1 | TREATMENT OF RHEUMATOID ARTHRITIS | SYNACT PHARMA APS (DK) | 2025-01-30 | — | — | US | disclosed |
| EP-4440572-A1 | TREATMENT OF RHEUMATOID ARTHRITIS | SynAct Pharma ApS (DK) | 2024-10-09 | — | — | EP | disclosed |
| CN-118613260-A | Treatment of rheumatoid arthritis | 西奈克制药有限公司 | 2024-09-06 | — | — | CN | disclosed |
| EP-4359383-A1 | SALTS OF PHENYL PYRROLE AMINOGUANIDINE AND POLYMORPHS OF PHENYL PYRROLE AMINOGUANIDINIUM SALTS | SynAct Pharma ApS (DK) | 2024-05-01 | — | — | EP | disclosed |
| CN-117836271-A | Salts of phenylpyrrolaminoguanidine and polymorphs of phenylpyrrolaminoguanidine onium salts | 西奈克制药有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023094692-A1 | TREATMENT OF RHEUMATOID ARTHRITIS | SYNACT PHARMA APS (DK) | 2023-06-01 | — | — | WO | disclosed |
| WO-2022268814-A1 | SALTS OF PHENYL PYRROLE AMINOGUANIDINE AND POLYMORPHS OF PHENYL PYRROLE AMINOGUANIDINIUM SALTS | SYNACT PHARMA APS (DK) | 2022-12-29 | — | — | WO | disclosed |
| CN-1085549-A | Cyanophenyl-pyrazolines | SCHERING AG (DE) | 1994-04-20 | — | — | CN | disclosed |
| US-5140048-A | Inhibitors of nonenzymatic cross-linking | THE ROCKEFELLER UNIVERSITY (US) | 1992-08-18 | — | — | US | disclosed |
| EP-0372603-A2 | Antibacterial oral composition | Colgate-Palmolive Company (US) | 1990-06-13 | — | — | EP | disclosed |
| EP-0316852-A2 | Inhibitors of nonenzymatic cross-linking | THE ROCKEFELLER UNIVERSITY (US) | 1989-05-24 | — | — | EP | disclosed |
| US-4266044-A | DIACETONEACRYLAMIDE-AMINOGUANIDINE MODIFIED POLYMERS HINDER DIFFUSION OF DYES AND OR COLOR COUPLERS | AGFA-GEVAERT N.V. (BE) | 1981-05-05 | — | — | US | disclosed |
| US-4145220-A | POLYMERS OF AMINOGUANIDINIUM SALTS OF DIACETONEACRYLAMIDE | AGFA-GEVAERT, N.V. (BE) | 1979-03-20 | — | — | US | disclosed |
| US-RE29168-E | HEAT SENSITIVE, ANTIHALATION LAYER | EASTMAN KODAK COMPANY (US) | 1977-04-05 | — | — | US | disclosed |